4174.TWO
Price:
$28.05
Market Cap:
$3.69B
OBI Pharma, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing cutting-edge therapies for critical medical needs, specifically in the field of cancer, with operations spanning Taiwan and international markets. The company's extensive product pipeline features numerous advanced treatment candidates. These include Adagloxad Simolenin (OBI-822), an active immunity drug for breast cancer designed to stimulate antibody production against the tumor carbohydrate antigen Globo H; OBI-833, an immunity-boosting anti-cancer agent targeting lung cancer; OBI-866 SSEA-4, another active immune-oncology medication; and OBI-888, a passive immunotherapy monoclonal antibody also deve...[Read more]
Industry
Biotechnology
IPO Date
2012-12-12
Stock Exchange
TWO
Ticker
4174.TWO
According to OBI Pharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.90. This represents a change of -48.61% compared to the average of -1.75 of the last 4 quarters.
The mean historical PE Ratio of OBI Pharma, Inc. over the last ten years is -8.24. The current -0.90 PE Ratio has changed 991.69% with respect to the historical average. Over the past ten years (40 quarters), 4174.TWO's PE Ratio was at its highest in in the June 2023 quarter at 6.76. The PE Ratio was at its lowest in in the June 2016 quarter at -90.40.
Average
-8.24
Median
-8.15
Minimum
-21.76
Maximum
-1.73
Discovering the peaks and valleys of OBI Pharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 88.24%
Maximum Annual PE Ratio = -1.73
Minimum Annual Increase = -62.17%
Minimum Annual PE Ratio = -21.76
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -1.73 | -41.52% |
| 2024 | -2.96 | -60.89% |
| 2023 | -7.56 | 88.24% |
| 2022 | -4.02 | -38.79% |
| 2021 | -6.56 | -28.74% |
| 2020 | -9.21 | 5.36% |
| 2019 | -8.74 | -17.28% |
| 2018 | -10.57 | 13.11% |
| 2017 | -9.34 | -57.06% |
| 2016 | -21.76 | -62.17% |
The current PE Ratio of OBI Pharma, Inc. (4174.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.08
5-year avg
-4.57
10-year avg
-8.24
OBI Pharma, Inc.’s PE Ratio is greater than Formosa Pharmaceuticals, Inc. (-64.85), less than TaiGen Biopharmaceuticals Holdings Limited (116.01), greater than Pharmosa Biopharm Inc. (-12.17), greater than BRIM Biotechnology, Inc. (-6.53), greater than Mycenax Biotech Inc. (-11.92), greater than CHO Pharma, Inc. (-61.47), less than Savior Lifetec Corporation (25.56), less than Sinphar Pharmaceutical Co.,Ltd. (17.04), less than Panion & Bf Biotech Inc. (24.17), less than PharmaEngine, Inc. (19.28),
| Company | PE Ratio | Market cap |
|---|---|---|
| -64.85 | $3.77B | |
| 116.01 | $6.21B | |
| -12.17 | $4.69B | |
| -6.53 | $2.94B | |
| -11.92 | $5.16B | |
| -61.47 | $17.83B | |
| 25.56 | $6.16B | |
| 17.04 | $6.06B | |
| 24.17 | $5.14B | |
| 19.28 | $8.15B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OBI Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like OBI Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is OBI Pharma, Inc.'s PE Ratio?
How is the PE Ratio calculated for OBI Pharma, Inc. (4174.TWO)?
What is the highest PE Ratio for OBI Pharma, Inc. (4174.TWO)?
What is the 3-year average PE Ratio for OBI Pharma, Inc. (4174.TWO)?
What is the 5-year average PE Ratio for OBI Pharma, Inc. (4174.TWO)?
How does the current PE Ratio for OBI Pharma, Inc. (4174.TWO) compare to its historical average?